Southeast Asia Antiviral Drug Market - By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Application (HIV, Hepatitis, Influenza), By Type (Branded, Generic), and By Region (Indonesia, Malaysia, Philippines, Thailand, Vietnam, Singapore, Myanmar, Rest of Southeast Asia)- Forecast from 2020-2027.

Southeast Asia Antiviral Drug Market growing owing to fueling the need for treatment of viral diseases and increasing immune system
The Southeast Asia antiviral drug market has the potential to grow with propelling CAGR in the forecast period from 2020-2027. The emerging demand for the antiviral drug in Southeast Asia is mainly owing to emerging viral diseases, low immunity systems, the prevalence of hepatitis C and influenza is driving the market share.
With the emergence of anti-hepatitis C drugs and a new generation of anti-AIDS drugs, the market pattern of antiviral medications has quietly changed. The effective antiviral therapies are propelling the treatment of AIDS has improved the life of the patients.
The market value of anti-hepatitis C drugs and anti-AIDS drugs is the main factor driving the growth of the Southeast Asia antiviral drug market. With the advent of new anti-hepatitis C drugs and the birth of new anti-AIDS drugs and multiple anti-AIDS drug compound preparations with different mechanisms of action, the Southeast Asia antiviral drug market will continue to expand.
 

Moreover, Antiviral drugs can reduce symptoms and shorten the period of illness, just like the role of seasonal flu. These drugs can also help prevent severe disease and death. The mechanism of antiviral drugs is to achieve resistance to further infection of the virus by affecting a specific part of the interference virus replication cycle.
 

Drug Class overview in the Southeast Asia antiviral drug market
Based on the drug class, the Southeast Asia antiviral drug market segment into DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others. The Reverse Transcriptase Inhibitors segment accounted for the largest share in the Southeast Asia antiviral drug market. Reverse Transcriptase Inhibitors is the first drug to fight against the human immunodeficiency virus and treat acquired immune deficiency syndrome (AIDS). The development of nucleotide HIV reverse transcriptase inhibitors (NRTI), non-nucleotide HIV reverse transcriptase inhibitors (NNRTI), HIV protease inhibitors (PI) has sprung up, and the development trend is rapid. The speed ranked as the first ant-viral drugs.
 

Application overview in the Southeast Asia antiviral drug market
Based on the application, the Southeast Asia antiviral drug market classified into HIV, Hepatitis, Influenza. The Hepatitis segment is estimated to dominates the maximum share of Southeast Asia antiviral drug market in the forecast period. These drugs can slow or stop the hepatitis virus, thereby reducing liver inflammation and damage. Antiviral drugs recommended as they are safer and most effective. Compared with the old antiviral medications, they also have better drug resistance, which means that when they have taken as prescribed, mutations and drug resistance are less likely to occur.
 

Type overview in the Southeast Asia antiviral drug market
Based on the type, the Southeast Asia antiviral drug bifurcated into Branded, Generic. Branded dominates the largest market share in the Southeast Asia antiviral drug market. It is mainly due to the belief in people that branded drugs help in curing the disease faster than generic. Moreover, branded drugs certified by the government and also prescribed by the doctors. Therefore, the demand for branded medications is higher than generic drugs.
 

Region overview in the Southeast Asia antiviral drug market
Based on geography, the Southeast Asia antiviral drug market segmented Indonesia, Malaysia, Philippines, Thailand, Vietnam, Singapore, Myanmar, Rest of Southeast Asia. Vietnam region is capturing the largest market share of the Southeast Asia antiviral drug market. It is mainly owing to the awareness among people regarding the viral diseases and availability of antiviral drugs used for the treatment of HIV disease is propelling the market demand for the antiviral drug in Vietnam.
 

Southeast Asia antiviral drug Market: Competitive Landscape
Companies such as Gilead Sciences, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, AbbVie, Merck & Co., Inc., Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, Cipla Inc., Aurobindo Pharma, Dr. Reddy’s Laboratories and others are key players in the Southeast Asia antiviral drug market.

Southeast Asia Antiviral Drug Market
Report Content
1. Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation
2. Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation
3. Executive Summary
4. Market Insights
4.1. Supply Chain Analysis
4.2. Economic Factor Analysis
4.2.1. Drivers
4.2.2. Trends
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape
4.4. Competitors & Product Analysis
4.5. Export-Import Analysis
4.6. Regulatory Framework
4.7. Company market share analysis, 2019
4.8. Porter’s Five forces analysis
4.9. New Investment Analysis
4.10. PESTEL Analysis
5. Southeast Asia Antiviral Drug Market Overview
5.1. Market Size & Forecast, 2016-2027
5.1.1. Demand
5.1.1.1. By Value (USD Billion)
5.2. Market Share & Forecast, 2016-2027
5.2.1. By Drug Class
5.2.1.1. DNA Polymerase Inhibitors
5.2.1.2. Reverse Transcriptase Inhibitors
5.2.1.3. Protease Inhibitors
5.2.1.4. Neuraminidase Inhibitors
5.2.1.5. Others
5.2.2. By Type
5.2.2.1. Branded
5.2.2.2. Generic
5.2.3. By Application
5.2.3.1. HIV
5.2.3.2. Hepatitis
5.2.3.3. Herpes
5.2.3.4. Influenza
5.2.3.5. Others
5.2.4. By Country
5.2.4.1. Indonesia
5.2.4.2. Malaysia
5.2.4.3. Philippines
5.2.4.4. Thailand
5.2.4.5. Vietnam
5.2.4.6. Singapore
5.2.4.7. Myanmar
5.2.4.8. Rest of Southeast Asia
6. Singapore Antiviral Drug Market Overview
6.1. Singapore Antiviral Drug Market Size & Forecast, 2016-2027
6.1.1. Demand
6.1.1.1. By Value (USD Billion)
6.2. Singapore Antiviral Drug Market Share & Forecast, 2016-2027
6.2.1. By Drug Class
6.2.1.1. DNA Polymerase Inhibitors
6.2.1.2. Reverse Transcriptase Inhibitors
6.2.1.3. Protease Inhibitors
6.2.1.4. Neuraminidase Inhibitors
6.2.1.5. Others
6.2.2. By Type
6.2.2.1. Branded
6.2.2.2. Generic
6.2.3. By Application
6.2.3.1. HIV
6.2.3.2. Hepatitis
6.2.3.3. Herpes
6.2.3.4. Influenza
6.2.3.5. Others
6.2.4. Price-Point Analysis
6.2.5. Manufacturer & Distributor List (Top 5)
6.2.6. Company Market Share (Top 3-5)
6.2.7. Economic Impact Study on Singapore Antiviral Drug Market
7. Malaysia Antiviral Drug Market Overview
7.1. Malaysia Antiviral Drug Market Size & Forecast, 2016-2027
7.1.1. Demand
7.1.1.1. By Value (USD Billion)
7.2. Malaysia Antiviral Drug Market Share & Forecast, 2016-2027
7.2.1. By Drug Class
7.2.1.1. DNA Polymerase Inhibitors
7.2.1.2. Reverse Transcriptase Inhibitors
7.2.1.3. Protease Inhibitors
7.2.1.4. Neuraminidase Inhibitors
7.2.1.5. Others
7.2.2. By Type
7.2.2.1. Branded
7.2.2.2. Generic
7.2.3. By Application
7.2.3.1. HIV
7.2.3.2. Hepatitis
7.2.3.3. Herpes
7.2.3.4. Influenza
7.2.3.5. Others
7.2.4. Price-Point Analysis
7.2.5. Manufacturer & Distributor List (Top 5)
7.2.6. Company Market Share (Top 3-5)
7.2.7. Economic Impact Study on Malaysia Antiviral Drug Market
8. Vietnam Antiviral Drug Market Overview
8.1. Vietnam Antiviral Drug Market Size & Forecast, 2016-2027
8.1.1. Demand
8.1.1.1. By Value (USD Billion)
8.2. Vietnam Antiviral Drug Market Share & Forecast, 2016-2027
8.2.1. By Drug Class
8.2.1.1. DNA Polymerase Inhibitors
8.2.1.2. Reverse Transcriptase Inhibitors
8.2.1.3. Protease Inhibitors
8.2.1.4. Neuraminidase Inhibitors
8.2.1.5. Others
8.2.2. By Type
8.2.2.1. Branded
8.2.2.2. Generic
8.2.3. By Application
8.2.3.1. HIV
8.2.3.2. Hepatitis
8.2.3.3. Herpes
8.2.3.4. Influenza
8.2.3.5. Others
8.2.4. Price-Point Analysis
8.2.5. Manufacturer & Distributor List (Top 5)
8.2.6. Company Market Share (Top 3-5)
8.2.7. Economic Impact Study on Vietnam Antiviral Drug Market
9. Indonesia Antiviral Drug Market Overview
9.1. Indonesia Antiviral Drug Market Size & Forecast, 2016-2027
9.1.1. Demand
9.1.1.1. By Value (USD Billion)
9.2. Indonesia Antiviral Drug Market Share & Forecast, 2016-2027
9.2.1. By Drug Class
9.2.1.1. DNA Polymerase Inhibitors
9.2.1.2. Reverse Transcriptase Inhibitors
9.2.1.3. Protease Inhibitors
9.2.1.4. Neuraminidase Inhibitors
9.2.1.5. Others
9.2.2. By Type
9.2.2.1. Branded
9.2.2.2. Generic
9.2.3. By Application
9.2.3.1. HIV
9.2.3.2. Hepatitis
9.2.3.3. Herpes
9.2.3.4. Influenza
9.2.3.5. Others
9.2.4. Price-Point Analysis
9.2.5. Manufacturer & Distributor List (Top 5)
9.2.6. Company Market Share (Top 3-5)
9.2.7. Economic Impact Study on Indonesia Antiviral Drug Market
10. Thailand Antiviral Drug Market Overview
10.1. Thailand Antiviral Drug Market Size & Forecast, 2016-2027
10.1.1. Demand
10.1.1.1. By Value (USD Billion)
10.2. Thailand Antiviral Drug Market Share & Forecast, 2016-2027
10.2.1. By Drug Class
10.2.1.1. DNA Polymerase Inhibitors
10.2.1.2. Reverse Transcriptase Inhibitors
10.2.1.3. Protease Inhibitors
10.2.1.4. Neuraminidase Inhibitors
10.2.1.5. Others
10.2.2. By Type
10.2.2.1. Branded
10.2.2.2. Generic
10.2.3. By Application
10.2.3.1. HIV
10.2.3.2. Hepatitis
10.2.3.3. Herpes
10.2.3.4. Influenza
10.2.3.5. Others
10.2.4. Price-Point Analysis
10.2.5. Manufacturer & Distributor List (Top 5)
10.2.6. Company Market Share (Top 3-5)
10.2.7. Economic Impact Study on Thailand Antiviral Drug Market
11. Rest of Southeast Asia Antiviral Drug Market Overview
11.1. Rest of Southeast Antiviral Drug Market Size & Forecast, 2016-2027
11.1.1. Demand
11.1.1.1. By Value (USD Billion)
11.2. Rest of Southeast Asia Antiviral Drug Market Share & Forecast, 2016-2027
11.2.1. By Drug Class
11.2.1.1. DNA Polymerase Inhibitors
11.2.1.2. Reverse Transcriptase Inhibitors
11.2.1.3. Protease Inhibitors
11.2.1.4. Neuraminidase Inhibitors
11.2.1.5. Others
11.2.2. By Type
11.2.2.1. Branded
11.2.2.2. Generic
11.2.3. By Application
11.2.3.1. HIV
11.2.3.2. Hepatitis
11.2.3.3. Herpes
11.2.3.4. Influenza
11.2.3.5. Others
11.2.4. By Country
11.2.4.1. Philippines
11.2.4.2. Myanmar
11.2.4.3. Brunei
11.2.4.4. Cambodia
11.2.4.5. Laos
11.2.5. Price-Point Analysis
11.2.6. Manufacturer & Distributor List (Top 5)
11.2.7. Company Market Share (Top 3-5)
11.2.8. Economic Impact Study on Rest of Southeast Asia Antiviral Drug Market

12. Competitor Analysis
12.1. Company Description
12.2. Financial Analysis
12.3. Key Products
12.4. Key Management Personnel
12.5. Contact Address
12.6. SWOT Analysis
12.7. Company Profile
12.7.1. Gilead sciences
12.7.2. F. Hoffmann-La Roche AG
12.7.3. GlaxoSmithKline plc
12.7.4. AbbVie
12.7.5. Merck & Co., Inc.
12.7.6. Johnson & Johnson Services, Inc.
12.7.7. Bristol-Myers Squibb Company
12.7.8. Cipla Inc.
12.7.9. Aurobindo Pharma
12.7.10. Dr. Reddy’s Laboratories
12.7.11. Other Prominent Players


Southeast Asia Air Purifier Market by Product (Dust collectors, Fume & smoke collectors, Vehicle exhaust, Mist eliminators, Fire/Emergency exhaust and Others), by Technology (High Efficiency Particulate Air (HEPA), Activated Carbon filters, Electrostatic Precipitators, ionic filters, UV light technology and others)

Southeast Asia Air Purifier market expected to drive due to the growing health problems due to air pollution, increasing urbanization and industrialization and the surge in consumer spending powerThe Southeast

USD 4950 View Report

Southeast Asia Air Purifier Market by Product (Dust collectors, Fume & smoke collectors, Vehicle exhaust, Mist eliminators, Fire/Emergency exhaust and Others), by Technology (High Efficiency Particulate Air (HEPA), Activated Carbon filters, Electrostatic Precipitators, ionic filters, UV light technology and others)

Southeast Asia Air Purifier market expected to drive due to the growing health problems due to air pollution, increasing urbanization and industrialization and the surge in consumer spending powerThe Southeast

USD 4950 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available